From October 1, 2020 to December 31, 2020, the company has repurchased 2,000 shares, representing 0.002949% for KRW 41.27 million. With this, the company has completed the repurchase of 71,714 shares, representing 0.11% for KRW 960.15 million under the buyback announced on March 13, 2020.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,550 KRW | -0.20% | -18.79% | -17.48% |
20/05 | HLB bioStep Co.,Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares. | CI |
20/05 | HLB bioStep Co.,Ltd. authorizes a Buyback Plan. | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.48% | 160M | |
-26.90% | 9.98B | |
-16.78% | 2.75B | |
-17.50% | 2.07B | |
-24.25% | 1.59B | |
+64.58% | 1.43B | |
+31.92% | 824M | |
-5.02% | 733M | |
-29.59% | 508M | |
+0.20% | 296M |
- Stock Market
- Equities
- A278650 Stock
- News HLB bioStep Co.,Ltd.
- Tranche Update on KNOTUS Co.,Ltd's Equity Buyback Plan announced on March 13, 2020.